
Integer Holdings (ITGR) Stock Forecast & Price Target
Integer Holdings (ITGR) Analyst Ratings
Bulls say
Integer Holdings Corp is positioned for a positive financial outlook, evidenced by a 15% revenue increase in the Cardio & Vascular segment for 3Q25 and projections for revenues to reach $1.87 billion in 2026, representing a 1.5% growth over the previous year. The company is expected to maintain strong gross margins of approximately 27% over the next two years, supported by stable operating cash flow that is forecasted to rise to between $230-$240 million in 2025, contributing to improved leverage ratios. Furthermore, the robust growth anticipated in the cardiovascular device market, fueled by ongoing product innovation and favorable demographic trends, aligns well with Integer's strategic positioning and efforts to expand its product offerings.
Bears say
Integer Holdings Corp has revised its financial projections for 4Q25, indicating anticipated revenues of $460.0 million, which represents only a modest 2% increase year-over-year but is down from a previous estimate of $477.0 million. The company has also lowered its full-year 2025 revenue guidance by $16 million and introduced a concerning flat-to-lower revenue outlook for 2026, which has been attributed to reduced demand for several key products. Furthermore, the projected sales growth of 0-4% reflects a significant decline from historical expectations of outperforming the market, driven by slower adoption of key products in the company's portfolio.
This aggregate rating is based on analysts' research of Integer Holdings and is not a guaranteed prediction by Public.com or investment advice.
Integer Holdings (ITGR) Analyst Forecast & Price Prediction
Start investing in Integer Holdings (ITGR)
Order type
Buy in
Order amount
Est. shares
0 shares